Skip to content

SoftCon (Vifilcon A) Soft Contact Corrective Lens

by Ciba Vision Care

PMA N17554

Active United States

PMA

Valid until

No expiry

PMA approval is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

PMA N17554

FDA record

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA PMA, synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA PMAAPPR Approved 1 supplement NumberN17554 Date1 Jul 1985ApprovedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA PMA Active

Specification

PMA

Trade Name
Softcon Contact Lens
Generic Name
Lenses, soft contact, daily wear
PMA Number
FDA Product Code
LPL
Device Class
Class II
Regulation
21 CFR Part 886.5925
Advisory Committee
Ophthalmic
FDA Decision
APPR Approved
PMA Supplement
S003

Overview

AI-generated summary, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

This device is a Lenses, Soft Contact, Daily Wear, designed for vision correction. It is a soft contact lens made from Vifilcon A material, intended for daily wear to correct refractive errors in the eye. The lens is classified as a Class II medical device under FDA regulations, requiring a Premarket Approval (PMA).

The SoftCon (Vifilcon A) Soft Contact Corrective Lens is supplied as a single-use, disposable product for daily wear. It is not intended for overnight or extended wear. The lens is regulated under FDA PMA (N17554) and falls under the product code LPL. No specific MRI safety information is provided, and storage conditions are not detailed in the available data.

Other devices from Ciba Vision Care

See all devices from Ciba Vision Care →

Questions

AI-generated answers, 18 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the primary use of the SOFTCON (VIFILCON A) Soft Contact Corrective Lens, and who would benefit from it?

    The SOFTCON (VIFILCON A) Soft Contact Corrective Lens is designed for daily wear only to correct refractive errors in the eye, such as nearsightedness, farsightedness, or astigmatism. It is intended for patients who require vision correction and prefer the convenience of soft contact lenses over glasses or other corrective methods. Since it is not approved for overnight or extended wear, it is best suited for individuals who need daytime correction without the commitment of reusable lenses.

  • Is this lens single-use or reusable, and how should it be handled after opening?

    The SOFTCON (VIFILCON A) Soft Contact Corrective Lens is explicitly labeled as a single-use, disposable product. Each lens is intended for one-time wear only and should not be reused. After opening the packaging, the lens should be handled with care to avoid contamination, and it must be discarded after use to maintain hygiene and safety standards.

  • Are there specific storage instructions provided for this lens, and what should I consider when storing it?

    The provided data does not include detailed storage instructions for the SOFTCON (VIFILCON A) lens. However, as a single-use, disposable soft contact lens, it is typically recommended to store it in a clean, dry environment away from direct sunlight or extreme temperatures until use. Since it is not reusable, storage considerations are primarily relevant for unopened packaging. Always follow manufacturer guidelines if additional instructions are available.

  • What regulatory pathway was followed for this device, and how does that affect its availability?

    The SOFTCON (VIFILCON A) Soft Contact Corrective Lens was approved through the FDA Premarket Approval (PMA) process, specifically under PMA number N17554. This pathway is required for Class II medical devices, ensuring rigorous evaluation of safety and effectiveness before market authorization. The device is classified under the product code LPL and is regulated as a Class II device under FDA regulations. Availability is governed by FDA compliance, meaning it must meet all approved specifications and labeling requirements.